TP53 and neoplasm: An interesting mechanism linking metabolic changes to tumour cell death was described by Long et al. [25]: ARs are activated by elevated eADO levels but ADO accumulation also activates the well-known wild-type tumour protein p53 (TP53), which in turn upregulates A2BR expression.